Reactivating Mitochondrial Function: a Novel Therapeutic Paradigm for Idiopathic Pulmonary Fibrosis. Using Levothyroxine Nanoparticles in Respirable Powder- LevoNano-IPF

Position: Research appointment (pre-doc) Institute: Uni. Parma
Posted on: 19/01/2026 Elapsing! Deadline: 03/02/2026

Scientific-Disciplinary Group

03/CHEM-08 - Technology, Socioeconomics And Regulation Of Medicinal And Health And Wellbeing Products

Description

The project has the objective of shaping a new therapeutic paradigm for the treatment of idiopathic pulmonary fibrosis through an innovative therapy aimed at reactivating the mitochondrial function of lung epithelial cells using levothyroxine nanoparticles in the form of dry powder for inhalation. Starting from promising preliminary data obtained in vitro with an innovative nanoformulation

Number of positions

1

Funding body

MUR